Nathan Yakubu Shehu, Mark Ojogba Okolo, Emmanuel Ameh Ameh, Daniel Geofrey Thankgod, Oluwatoyin Ruth Morenikeji, Ferdinand Ibu Ogbaji, Dung Davou Pam, Filibus Danjuma Dami, Pam Dachung Luka
{"title":"Is there Co-infection of Influenza and Covid-19 in Jos, North Central Nigeria?","authors":"Nathan Yakubu Shehu, Mark Ojogba Okolo, Emmanuel Ameh Ameh, Daniel Geofrey Thankgod, Oluwatoyin Ruth Morenikeji, Ferdinand Ibu Ogbaji, Dung Davou Pam, Filibus Danjuma Dami, Pam Dachung Luka","doi":"10.71480/nmj.v66i1.342","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Influenza virus and severe acute respiratory syndrome virus-2 (SARS CoV-2) are known to cause respiratory disease in humans that may be fatal. They have caused epidemics and constitute significant public health challenges because of their ability to spread and cause severe disease. Co-infection with both viruses has been shown to increase the odds of fatality among affected patients. Our study aimed to investigate co-infection with influenza among patients with coronavirus disease-2019 (COVID-19) in Jos, Plateau State.</p><p><strong>Methodology: </strong>We carried out a cross-sectional study using stored nasopharyngeal and oropharyngeal samples of patients diagnosed with COVID-19 using GeneXpert. The samples were collected at our institution and stored at -80 °C. The samples were analysed for influenza co-infection using real-time reverse transcriptase polymerase chain reaction.</p><p><strong>Results: </strong>Two-hundred-and-forty-one (241) stored samples of patients diagnosed with COVID-19 were analysed. None of the samples tested positive for the influenza virus.</p><p><strong>Conclusion: </strong>We found no case of influenza and SARS-CoV-2 co-infection among the patients studied. This suggests that the prevalence of influenza virus infection may be low in our setting and partly explains the relatively benign outcome of SARS-CoV-2 infections in our region.</p>","PeriodicalId":94346,"journal":{"name":"Nigerian medical journal : journal of the Nigeria Medical Association","volume":"66 1","pages":"357-363"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12038622/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian medical journal : journal of the Nigeria Medical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.71480/nmj.v66i1.342","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Influenza virus and severe acute respiratory syndrome virus-2 (SARS CoV-2) are known to cause respiratory disease in humans that may be fatal. They have caused epidemics and constitute significant public health challenges because of their ability to spread and cause severe disease. Co-infection with both viruses has been shown to increase the odds of fatality among affected patients. Our study aimed to investigate co-infection with influenza among patients with coronavirus disease-2019 (COVID-19) in Jos, Plateau State.
Methodology: We carried out a cross-sectional study using stored nasopharyngeal and oropharyngeal samples of patients diagnosed with COVID-19 using GeneXpert. The samples were collected at our institution and stored at -80 °C. The samples were analysed for influenza co-infection using real-time reverse transcriptase polymerase chain reaction.
Results: Two-hundred-and-forty-one (241) stored samples of patients diagnosed with COVID-19 were analysed. None of the samples tested positive for the influenza virus.
Conclusion: We found no case of influenza and SARS-CoV-2 co-infection among the patients studied. This suggests that the prevalence of influenza virus infection may be low in our setting and partly explains the relatively benign outcome of SARS-CoV-2 infections in our region.